Atherosclerotic Cardiovascular Disease
📧 Sign up to get email alerts when something new happens for Atherosclerotic Cardiovascular Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors
A clinical trial investigating late subclinical cardiovascular disease in testicular cancer survivors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events [Phase 2]
Phase 2 trial evaluating SLN360 in participants with elevated lipoprotein(a) at high risk of atherosclerotic cardiovascular disease. The tri…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Telehealth Group Counseling and Preventive Care for Women [NA]
A completed clinical trial evaluating telehealth group counseling and preventive care for women with cardiovascular conditions, including AS…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Patterns of Inclisiran Use in the Real World: An Analysis of US Databases
This clinical trial update analyzes real-world use patterns of inclisiran in US databases for patients with atherosclerotic cardiovascular d…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease [Phase 2]
Phase 2 trial evaluating Novo Nordisk’s NNC0385-0434 tablets for lowering blood cholesterol in people with atherosclerotic cardiovascular di…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World
A completed real-world study evaluating the effect of semaglutide on cardiovascular outcomes in adults with overweight or obesity.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease [Phase 1]
Phase 1 trial update reporting completion of the study of VERVE-101 in patients with heterozygous familial hypercholesterolemia and cardiova…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis [Phase 1, Phase 2]
It reports the completion of a Phase 1/Phase 2 trial of YN001 in healthy subjects and patients with atherosclerotic cardiovascular disease (…
-
CLINICAL_TRIALS trial_result · 2025-04-11Clinical Trial Update: LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering [Phase 4]
Phase 4 clinical trial updating LDL-C optimization with inclisiran for patients in whom drug-drug interactions limit LDL lowering; currently…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events [Phase 2]
Phase 2 trial of LY3473329 in adults with elevated lipoprotein(a) at high risk for cardiovascular events has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2025-03-24Clinical Trial Update: Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector
This entry reports the completion of a non-interventional study evaluating monthly 300 mg alirocumab (PRALUENT) administered using the SYDNE…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Diagnostic Accuracy Of Seismocardiography for Coronary Artery Disease [NA]
This completed clinical trial, sponsored by Heart Force Medical Inc., evaluated the diagnostic accuracy of seismocardiography for coronary a…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia [Phase 3]
A Phase 3 study evaluating the efficacy and safety of HST101 in Chinese patients with hypercholesterolemia and related dyslipidemias; the tr…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
The REVEALPLAQUE trial, a prospective multicenter study using coronary CT angiography to analyze plaque, has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Behavioral Economic Approaches to Increase Physical Activity Among Patients With Elevated Risk for Cardiovascular Disease [NA]
A completed clinical trial evaluating behavioral economic approaches to increase physical activity among patients at elevated risk for cardi…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) [NA]
The v-ASCERTAIN implementation study sponsored by Monash University has been terminated, involving conditions including atherosclerotic card…
-
CLINICAL_TRIALS trial_result · 2025-01-20Clinical Trial Update: Effect of Ezetimibe on Gut Microbiota [Phase 4]
Phase 4 clinical trial evaluating the effect of ezetimibe on gut microbiota in patients with atherosclerotic cardiovascular disease and dysl…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Trial to Evaluate Efficacy and Safety of LIB003 and Inclisiran in High-risk CVD Patients [Phase 3]
Phase 3 trial evaluating LIB003 in combination with Inclisiran for efficacy and safety in high-risk cardiovascular disease patients has comp…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) [Phase 3]
Phase 3 trial comparing an 'Inclisiran First' implementation strategy to usual care in patients with atherosclerotic cardiovascular disease …
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID) [NA]
This update reports the completion and results posting of PROMPT-LIPID, a pragmatic trial assessing whether targeted messaging to providers …
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED) [Phase 3]
A completed Phase 3 trial evaluated MK0653A in combination with simvastatin for cholesterol lowering in patients with hypercholesterolemia a…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Recipe for Heart Health [NA]
A completed clinical trial update from the University of Florida related to atherosclerotic cardiovascular disease. The study status is comp…
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Real Life Lipid Management in Hospitals Not Participating in PENELOPE Trial - Control Population for PENELOPE
Real-world lipid management study is completed, serving as the control population for the PENELOPE trial.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists
This completed study assessed real-world awareness and perceptions of systemic inflammation and the role of hsCRP as a biomarker among nephr…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia
This completed real-world study evaluated adherence, treatment patterns, patient characteristics, and effectiveness of Inclisiran in patient…